Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
Hervé
P
P
BMT Centers of Besançon.
Racadot
E
E
Wijdenes
J
J
Flesch
M
M
Tiberghien
P
P
Bordigoni
P
P
Holler
E
E
Powles
M
M
Bourdeau
M
M
Wilmer
E
E
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004341:Drug Evaluation; D004351:Drug Resistance; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha